Back
Vaxart 10K Form
Sell
29
VXRT
Vaxart
Last Price:
0.60
Seasonality Move:
17.65%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VXRT News And Ratings
See the #1 stock for the next 7 days that we like better than VXRT
VXRT Financial Statistics
Sales & Book Value
| Annual Sales: | $7.38M |
|---|---|
| Cash Flow: | $-4.21M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.30 |
| Price / Book: | 1.99 |
Profitability
| EPS (TTM): | -0.41000 |
|---|---|
| Net Income (TTM): | $-72.34M |
| Gross Margin: | $21M |
| Return on Equity: | -108.46% |
| Return on Assets: | -63.84% |
Vaxart Earnings Forecast
Key Vaxart Financial Ratios
- The Gross Profit Margin over the past 30 years for VXRT is 85.37%.
- The Selling, General & Administrative Expenses for VXRT have been equal to 306.06% of Gross Profit Margin.
- The Research & Development expenses have been 923.46% of Revenue.
- The Interest Expense is -1.75% of Operating Income.
- The Net Earning history of VXRT is -1,117.56% of Total Revenues.
- Per Share Earnings over the last 38 years have been positive in 15 years.
Vaxart Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VXRT |
| CUSIP: | 92243A |
| Website: | vaxart.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0.83 |
| Quick Ratio: | 0.78 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |